Welcome.

Below you will find information about this National Vaccine Research Study for Transplant Recipients

COVID-19 Antibody Testing of Recipients of Solid Organ Transplants and Patients with Chronic Diseases is being led by the transplant team at Johns Hopkins. Our principal investigator is William Werbel, MD Instructor, Johns Hopkins Department of Infectious Disease. The study has been approved by the Johns Hopkins Institutional Review Board (IRB00248540)

The purpose of this research study is to determine COVID-19 antibody levels in transplant recipients
who get the COVID-19 vaccine. The study does not provide the vaccine, and study team members will not be offering guidance as to whether or not one should receive a SARS-CoV-2 vaccine. If participants have received or will be receiving a vaccine and are interested in the study, we will collect a blood sample before vaccination when possible, and collect samples at sequential time points post-immunization.

Thank you for your interest in our study of COVID-19 Antibody Testing of Recipients of Solid Organ Transplants and Patients with Chronic Diseases. Due to an overwhelming interest in our study, we have reached capacity and have closed enrollment at this time.